Co-Diagnostics, Inc. — Director's Dealing 2021

May 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2021-05-19

Reporting Person: BENSON REED L (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-19	Common Stock	M	1.00	$1.10	Acquired	1.00	Direct
2021-05-19	Common Stock	M	10920.00	$2.63	Acquired	10921.00	Direct
2021-05-19	Common Stock	M	97413.00	$2.63	Acquired	108334.00	Direct
2021-05-19	Common Stock	S	10920.00	$8.5377	Disposed	97414.00	Direct
2021-05-19	Common Stock	S	97413.00	$8.5244	Disposed	1.00	Direct
2021-05-19	Common Stock	S	1.00	$8.53	Disposed	0.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-19	Stock Option (Right to Buy)	$2.63	M	97413.00	Disposed	2028-09-20	Common Stock (97413.00)	Direct
2021-05-19	Stock Option (Right to Buy)	$2.63	M	10920.00	Disposed	2028-09-20	Common Stock (10920.00)	Direct
2021-05-19	Stock Option (Right to Buy)	$1.10	M	1.00	Disposed	2029-09-02	Common Stock (1.00)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $8.52 USD to $8.55 USD; the price reported above reflects the weighted average sale price.

F2: This transaction was executed in multiple trades at prices ranging from $8.47 USD to $8.64 USD; the price reported above reflects the weighted average sale price.

F3: 1/3 on day of grant; 1/3 after year 1, 1/3 after year 2 beginning on 21-Sep-2018

F4: 1/3 on day of grant; 1/3 after year 1, 1/3 after year 2 beginning on 03-Sep-2019